[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538872":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":44,"responsibleParty":95,"collaborators":97,"id":101,"slug":102,"hasResults":103,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":107,"eligibilityCriteria":108,"healthyVolunteers":103,"sex":109,"minAge":110,"maxAge":26,"enrollmentInfo":111,"targetDuration":26,"studyType":114,"phases":115,"briefSummary":117,"conditions":118,"keywords":121,"overallStatus":47,"whyStopped":26,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":133},{"fullName":5,"class":6},"Kaiser Permanente","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group Education Sessions","EXPERIMENTAL","Participants will participate in 3 educational sessions designed to teach about applying and using continuous glucose monitors \\[CGMs\\] (Session 1) and how to prevent hypoglycemia episodes based on CGM readings and hypoglycemia journal entries (Sessions 2 \\& 3).",[13],"Behavioral: SAGE Group Sessions",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","ACTIVE_COMPARATOR","Participants allocated to the control arm will continue with usual care.",[19],"Other: Usual Care",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","SAGE Group Sessions","Participants enroll in 3 educational group sessions and receive CGMs",[9],null,{"type":6,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Participants continue to receive usual care (Control Arm)",[15],[31],{"name":32,"affiliation":33,"role":34},"Richard W Grant, MD MPH","Kaiser Permanente Northern California - Division of Research","PRINCIPAL_INVESTIGATOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Carolina Gonzalez","CONTACT","866-206-2969","Susana.C.Gonzalez@kp.org",{"name":42,"role":38,"phone":26,"phoneExt":26,"email":43},"Nancy W Charvat-Aguilar","nancy.x.charvat-aguilar@kp.org",[45,62,73,84],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Kaiser Permanente Fremont","RECRUITING","Fremont","California","94538","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-121.98857,37.54827,{"lat":57,"lon":56},[60],{"name":61,"role":38,"phone":26,"phoneExt":26,"email":26},"Ilana A Peterson",{"facility":63,"status":47,"city":64,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Kaiser Permanente San Jose","San Jose",{"type":54,"coordinates":66},[67,68],-121.89496,37.33939,{"lat":68,"lon":67},[71],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":72},"susana.c.gonzalez@kp.org",{"facility":74,"status":47,"city":75,"state":49,"zip":76,"country":51,"countryCode":52,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Kaiser Permanente San Leandro","San Leandro","94577",{"type":54,"coordinates":78},[79,80],-122.15608,37.72493,{"lat":80,"lon":79},[83],{"name":61,"role":38,"phone":26,"phoneExt":26,"email":26},{"facility":85,"status":47,"city":86,"state":49,"zip":87,"country":51,"countryCode":52,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Kaiser Permanente - Union City","Union City","94587",{"type":54,"coordinates":89},[90,91],-122.01913,37.59577,{"lat":91,"lon":90},[94],{"name":61,"role":38,"phone":26,"phoneExt":26,"email":26},{"type":96,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[98],{"name":99,"class":100},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","NIH","100538872","safer-aging-with-diabetes-monitoring-100538872",false,"NCT06296485","Safer Aging With Diabetes Monitoring","Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes","SAGE","Inclusion Criteria:\n\n* Age 75 years and older\n* Diagnosis of Type 2 Diabetes\n* Current treatment with insulin\n* Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)\n* Able to communicate in English\n* Able to access email and the Internet\n\nExclusion Criteria:\n\n* On renal dialysis\n* Dementia\n* Pacemaker or Automatic Implantable Cardioverter Defibrillator\n* Using insulin pump\n* Severe Mental Illness\n* Severe Visual Impairment\n* In Hospice\n* Current or recent CGM use","ALL","75 Years",{"count":112,"type":113},360,"ESTIMATED","INTERVENTIONAL",[116],"NA","Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.",[119,120],"Diabetes Mellitus, Type 2","Hypoglycemia",[120,122,123],"Diabetes Education","Continuous Glucose Monitor","2025-04-21",{"date":126,"type":127},"2025-04-22","ACTUAL",{"date":129,"type":127},"2024-05-01",{"date":131,"type":113},"2028-01-31",{"name":5,"class":6},4]